SCHEMBL2316293

SCHEMBL2316293

COc1ccc(C(C)=NN)c(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
MAPK1 P28482 4/20 0.61
HPGD P15428 3/20 0.61
CYP3A4 P08684 3/20 0.61
RAB9A P51151 3/20 0.58
NPC1 O15118 2/20 0.58
MAPT P10636 5/20 0.52
GAA P10253 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
POLB P06746 1/20 0.52
APEX1 P27695 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 3/20 0.50
CYP2C19 P33261 3/20 0.50
CYP1A2 P05177 2/20 0.50
PGR P06401 2/20 0.50
SLC6A2 P23975 2/20 0.50
ADORA3 P0DMS8 1/20 0.50
AR P10275 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2317442 0.86 MAPT (0.50) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL1448162 0.84 MAPK1 (0.62) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL1448166 0.84 MAPK1 (0.62) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL1448167 0.84 MAPK1 (0.62) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL17307554 0.84 MAPK1 (0.62) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL17988362 0.84 MAPK1 (0.62) ALDH1A1MAPK1HPGDCYP3A4RAB9A
SCHEMBL4161187 0.82 MAPT (0.74) ALDH1A1HPGDCYP3A4RAB9ANPC1
SCHEMBL2693726 0.81 MAPT (0.54) ALDH1A1HPGDMAPTGAATDP1
SCHEMBL2314678 0.81 MAPT (0.54) ALDH1A1HPGDMAPTGAATDP1
Hydrochloric Acid SCHEMBL5703362 0.80 MAPT (0.57) ALDH1A1MAPK1HPGDCYP3A4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10367148-B2 Light-emitting device, electronic apparatus, and inspection method SEIKO EPSON CORPORATION (JP) 2019-07-30 US disclosed
US-9799836-B2 Light emitting element, light emitting device, authentication device, and electronic device SEIKO EPSON CORPORATION (JP) 2017-10-24 US disclosed
US-20170200901-A1 LIGHT-EMITTING DEVICE, ELECTRONIC APPARATUS, AND INSPECTION METHOD SEIKO EPSON CORPORATION (JP) 2017-07-13 US disclosed
EP-3151299-A1 LIGHT EMITTING DEVICE, ELECTRONIC APPARATUS, AND INSPECTION METHOD Seiko Epson Corporation (JP) 2017-04-05 EP disclosed
US-20150249213-A1 LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC DEVICE SEIKO EPSON CORPORATION (JP) 2015-09-03 US disclosed
US-20110189306-A1 COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES KARTNER NORBERT 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10367148-B2 Light-emitting device, electronic apparatus, and inspection method CRY1, INF2, CRY2 ALDH1A1 5/4885MAPK1 2598/4885HPGD 3958/4885
US-20170200901-A1 LIGHT-EMITTING DEVICE, ELECTRONIC APPARATUS, AND INSPECTION METHOD CRY1, INF2, CRY2 ALDH1A1 5/4885MAPK1 2598/4885HPGD 3958/4885
US-20110189306-A1 COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES ATP6V1E1, ATP6V1G1, ATP6V1H ALDH1A1 2068/4885MAPK1 3742/4885HPGD 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.